Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MODERNA | 27 | 16 | +5,98 % | ||
| ULTRAGENYX | 9 | - | -8,54 % | ||
| BIONTECH | 7 | 13 | +1,12 % | ||
| VERTEX PHARMACEUTICALS | 7 | 5 | +7,31 % | ||
| PTC THERAPEUTICS | 6 | 4 | 0,00 % | ||
| ALNYLAM PHARMACEUTICALS | 5 | 9 | +2,19 % | ||
| PACIFIC BIOSCIENCES OF CALIFORNIA | 5 | 3 | -5,65 % | ||
| AMGEN | 4 | 27 | +0,75 % | ||
| COHERUS ONCOLOGY | 4 | 1 | -15,96 % | ||
| CRISPR THERAPEUTICS | 4 | 1 | +9,22 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19:30 | Why Is Ultragenyx Stock Sinking Friday? | 1 | Benzinga.com | ||
| 19:26 | After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio | 2 | FierceBiotech | ||
| 19:22 | Biogen auf dem Piper Sandler Symposium: Strategischer Fokus auf die Behandlung von Lupus | 4 | Investing.com Deutsch | ||
| 18:54 | Moderna outlines up to 10% revenue growth for 2026 amid international expansion and cost discipline | 4 | Seeking Alpha | ||
| 18:51 | Biontech-Rivale Moderna wendet sich von US-Markt ab | 12 | manager-magazin.de | ||
| 18:46 | Ultragenyx cuts jobs as it seeks path to profit in 2027 | 1 | BioPharma Dive | ||
| 18:46 | Moderna shares jump as company affirms growth outlook | 2 | BioPharma Dive | ||
| 18:10 | Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year | 2 | FiercePharma | ||
| 18:10 | With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment | 7 | FiercePharma | ||
| 17:36 | Krystal Biotech Q4 2025 Earnings Preview | 2 | Seeking Alpha | ||
| 17:26 | Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg | 5 | FierceBiotech | ||
| 17:15 | Dividendenbekanntmachungen (13.02.2026) | 3.562 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6571 EUR A10 NETWORKS INC US0021211018 0,06 USD 0,0505 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen | |
| 17:10 | VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales | 11 | Zacks | ||
| 17:06 | Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms | 6 | Benzinga.com | ||
| 17:06 | 10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity | 1 | Investing.com | ||
| 16:54 | Upstream Bio's Selloff May Be 'Overdone,' But Analyst Highlights Asthma Drug's Competitive Edge Concerns | 6 | Benzinga.com | ||
| 16:47 | Moderna will 2026 wieder wachsen | 8 | cash | ||
| 16:30 | ROUNDUP/Nach Umsatzeinbruch: Moderna will 2026 wieder wachsen | 176 | dpa-AFX | CAMBRIDGE (dpa-AFX) - Ungeachtet eines überraschend starken Schlussquartals hat der US-Pharmakonzern Moderna 2025 einen harschen Umsatzeinbruch hinnehmen müssen. 2026 sollen die Erlöse nun wieder zulegen... ► Artikel lesen | |
| 16:30 | BREAKING: Biontech im Kaufrausch - Insider schlagen massiv zu - jetzt beachten! | Hebelschein-Spekulant | |||
| 16:18 | RBC Capital lowers Alnylam Pharmaceuticals stock price target on short-term headwinds | 5 | Investing.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.